<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03412539</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-0354-17-TLV</org_study_id>
    <nct_id>NCT03412539</nct_id>
  </id_info>
  <brief_title>Mechanism of Effectiveness of Neurosurgery Treatments for Durable Pain</brief_title>
  <official_title>Mechanism of Effectiveness of Neurosurgery Treatments for Durable Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Haifa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <brief_summary>
    <textblock>
      The participants in the study are patients who undergo surgery to damaged nerve transmission&#xD;
      and processing system in the nervous system as part of the routine clinical treatment that&#xD;
      will not be affected by the proposed study. Patients who are candidates for procedures are&#xD;
      referred from all over the country and undergo a multidisciplinary evaluation in the&#xD;
      framework of the Palliative Pain Management Clinic, which operates exclusively in Israel at&#xD;
      the Sourasky Medical Center in Tel Aviv.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participants in the study are patients who undergo surgery to damaged nerve transmission&#xD;
      and processing system in the nervous system as part of the routine clinical treatment that&#xD;
      will not be affected by the proposed study. Patients who are candidates for procedures are&#xD;
      referred from all over the country and undergo a multidisciplinary evaluation in the&#xD;
      framework of the Palliative Pain Management Clinic, which operates exclusively in Israel at&#xD;
      the Sourasky Medical Center in Tel Aviv.&#xD;
&#xD;
      During the preoperative evaluation, patients will be given an explanation about the&#xD;
      possibility of participating in the study. Patients who agree to participate will sign an&#xD;
      informed consent form.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <expanded_access_info>
    <expanded_access_type_individual>Yes</expanded_access_type_individual>
  </expanded_access_info>
  <condition>Oncology Problem</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing neurosurgical surgery for resistant pain&#xD;
&#xD;
          -  Ability to sign informed consent form for participation in the study&#xD;
&#xD;
          -  A functional level is sufficient for cooperation and the performance of various tasks&#xD;
             before and after surgery, including performing MRI's, answering pain questioners, and&#xD;
             neuropsychological evaluations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Ido Strauss, MD</last_name>
    <phone>972-3-6974949</phone>
    <email>idos@tlcmc.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neurosurgery, Tel-Aviv Sourasky MC</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>January 21, 2018</study_first_submitted>
  <study_first_submitted_qc>January 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2018</study_first_posted>
  <last_update_submitted>January 21, 2018</last_update_submitted>
  <last_update_submitted_qc>January 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>michal roll</investigator_full_name>
    <investigator_title>Dr Ido Strauss Neurosurgeon</investigator_title>
  </responsible_party>
  <keyword>resistant pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

